Riliprubart (SAR445088) is a humanised monoclonal antibody targeting C1s, applicable for neurological disorders such as CIDP, which inhibits activated C1s in the classical complement pathway.
Purity:
0.99
CAS Number:
[2756228-76-7]
Target:
Complement System
* VAT and and shipping costs not included. Errors and price changes excepted